What You Should Know: - Today, Veradigm and HealthVerity announced a collaboration to advance research and improve patient care for those with cardiovascular disease and diabetes. The collaboration makes Veradigm’s data from their Cardiovascular and Metabolic Registries fully interoperable with de-identified patient data from HealthVerity Marketplace, the nation’s largest healthcare and consumer data ecosystem. - The HealthVerity IPGE platform is an integrated technology and
Read More
Atrial Fibrillation
Anumana & Pfizer Partner on Amyloidosis AI-ECG Algorithm Development
What You Should Know: - Anumana, an AI-driven health technology company and portfolio company of nference, today announced a multi-year agreement with Pfizer for Anumana to develop an investigational artificial intelligence electrocardiogram algorithm (AI-ECG) designed to enable the early identification of patients who may be at risk of cardiac amyloidosis. - Anumana will conduct a clinical validation trial and pursue De Novo classification for the algorithm as a
Read More
Research Shows Power of Anumana AI-ECG Algorithms to Detect Heart Conditions
What You Should Know: - The research is mounting to show that Anumana’s AI-ECG algorithms could dramatically improve screening for cardiovascular disease (CVD), providing early warnings of disease from just a standard electrocardiogram (ECG). Yesterday, a study was published in Nature Medicine that shows an Anumana AI algorithm applied to Apple Watch ECG recordings successfully identified a weak heart pump in patients. - This follows other recent research findings, published in The
Read More
KLAS: 7 Key Healthcare Trends in Microsoft Cloud Technologies in 2022
What You Should Know: - A new report from KLAS focuses on healthcare-specific deployments of Microsoft Cloud Technologies, especially Microsoft Azure, which is receiving strong market interest. - This study is meant to help organizations considering Microsoft Cloud technologies understand their current use, the overall customer experience, and the impact of the solutions. Key Healthcare Trends in Microsoft Cloud Technologies in 2022 While still early, healthcare is gaining momentum
Read More
GE Healthcare Makes Strategic Investment in AliveCor
What You Should Know: - AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, recently announced its Series F Financing led by GE Healthcare. - The round also included participation from Pegasus Tech Ventures) and existing investors including Khosla Ventures, Bold Capital Partners, Qualcomm Ventures, and WP Global Partners. Providing End-to-End Cardiological Care Using Subscription Services AliveCor, Inc. is transforming cardiological care using deep
Read More
FDA Awards 510(k) Clearances for ZEUS System/Zio Watch
What You Should Know: - Today, iRhythm (a digital health company) and Verily (Alphabet’s life sciences research organization) announced joint FDA 510(k) clearances for the ZEUS System and Zio Watch. Together they create an integrated, prescription-based solution that will improve clinician workflows, care pathways and the patient experience. - The ZEUS System is the AI algorithm and solution component of the Zio Watch – a clinical grade, long-term and noninvasive wearable that not only
Read More
Analysis: How Will The Roadmap for Diagnostic Cardiology Devices Develop?
Like most healthcare markets, the diagnostic cardiology market has had a bumpy ride in recent years. The COVID-19 pandemic saw global revenues for Resting ECG devices increase in 2020, whilst ECG Management Systems, Stress ECG and Traditional Holter ECG solutions saw a market decline. Country lockdowns resulted in reduced cardiology services during the peak of the pandemic, as non-urgent appointments were delayed. 2021 showed relief for cardiac facilities as providers started to deal with the
Read More
Geisinger & Tempus Create AI Model to Identify Structural Heart Disease
What You Should Know: - Tempus, an $8B precision medicine company, announced a collaborative study with Geisinger focusing on artificial intelligence (AI) model that can accurately identify patients at increased risk of undiagnosed structural heart disease (SHD). The study addresses a critical diagnostic gap – SHD is a progressive disease that affects the valves, walls, chambers, and muscles of the heart, and causes debilitating symptoms or death, yet many patients with the disease go
Read More
Fitbit Receives FDA Clearance for New PPG Algorithm to Identify AFib
What You Should Know: - Fitbit announced it has received clearance from the FDA for its PPG (photoplethysmography) algorithm to identify atrial fibrillation (AFib), a condition that affects more than 33.5 million people globally. - The algorithm will soon be available to users in the U.S. through Fitbit’s new Irregular Heart Rhythm Notifications feature on eligible heart-rate tracking devices.
Read More
Eko Unveils Newly Designed Heart Disease Detection App
What You Should Know: - Eko, a digital health company advancing heart and lung disease detection, today announced the launch of its newly-redesigned Eko App, which will transform patient interactions into an opportunity to screen for cardiovascular disease. Heart disease is the leading cause of death in the U.S., and there has not been an efficient and affordable solution to screen for heart disease at the physical exam until now. - Eko has transformed the traditional stethoscope into an
Read More
